GAZETE OKSIJEN

From Bench to Bedside: first ever in Turkey

HABERTURK

International Women’s Day Interview with Prof. Rana Sanyal

SABAH

Biotech startup raises $12M in Series A Investment Round

WEBRAZZI

RS Research has raised $12M in Series-A investment round with GEN Ilac as the lead investor

HURRIYET

RS Research’s smart targeted drug candidate started phase-I clinical trial, recruiting patients

DUNYA

Turkey’s first new drug started phase-I clinical study

SABAH

Developing smart chemotherapy drugs against cancer, RS Research kicks-off Series-A funding round

MILLIYET

Named one of the 3 pioneers in science

HURRIYET

Ready to proceed with animal trials for smart drug candidate against COVID-19

EKONOMIST

Prof. Dr. Rana Sanyal was named Promising Female Entrepreneur 2019 by Garanti BBVA, Ekonomist and KAGİDER